These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6152456)

  • 41. [Familial adenomatosis-results of the Erlangen adenomatosis register].
    Giedl J; Altendorf A
    Verh Dtsch Ges Pathol; 1982; 66():136-41. PubMed ID: 6135286
    [No Abstract]   [Full Text] [Related]  

  • 42. Diagnostic usefulness of the calcitonin secretion induced with pentagastrin in the familial medullary thyroid carcinoma.
    González-Villalpando C; Madero A; Peña J; Ramírez R; Szymansky J; Ruiz JE; Zárate A
    Arch Invest Med (Mex); 1985; 16(3):237-45. PubMed ID: 2870690
    [No Abstract]   [Full Text] [Related]  

  • 43. Genetic diagnosis in multiple endocrine neoplasia type 2A.
    Morrison P
    Ir Med J; 1991 Mar; 84(1):6. PubMed ID: 1675208
    [No Abstract]   [Full Text] [Related]  

  • 44. Multiple endocrine neoplasia type 2: awaiting the gene.
    Lancet; 1992 Dec 19-26; 340(8834-8835):1510-1. PubMed ID: 1361604
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical genetics of neuroendocrine tumors].
    Karges W; Adler G
    Med Klin (Munich); 2003 Dec; 98(12):712-6. PubMed ID: 14685672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Multiple endocrine type 2 neoplasia in 3 families].
    Palchik M; Sánchez A; Góméz J; Rodríguez Pécora A
    Medicina (B Aires); 1990; 50(2):117-23. PubMed ID: 1983220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple endocrine neoplasia type I: assessment of laboratory tests to screen for the gene in a large kindred.
    Marx SJ; Vinik AI; Santen RJ; Floyd JC; Mills JL; Green J
    Medicine (Baltimore); 1986 Jul; 65(4):226-41. PubMed ID: 2873498
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
    Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
    Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.
    Lips CJ; Landsvater RM; Höppener JW; Geerdink RA; Blijham G; van Veen JM; van Gils AP; de Wit MJ; Zewald RA; Berends MJ
    N Engl J Med; 1994 Sep; 331(13):828-35. PubMed ID: 7915822
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds.
    Skogseid B; Eriksson B; Lundqvist G; Lörelius LE; Rastad J; Wide L; Akerström G; Oberg K
    J Clin Endocrinol Metab; 1991 Aug; 73(2):281-7. PubMed ID: 1677362
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulinomas in MEN-I patients: early detection and treatment of insulinomas in patients with the multiple endocrine neoplasia syndrome type-I.
    Jadoul M; Koppeschaar HP; Bax MA; Mali WP; Wit JM; Huber J; Vasen HF; Van der Sluys Veer J; Struyvenberg A; Lips CJ
    Neth J Med; 1990 Oct; 37(3-4):95-102. PubMed ID: 1979152
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of a family at risk for the multiple endocrine neoplasia type 2A (MEN 2A) syndrome.
    Mollentze WF; Jansen S; Nel CJ; Barry R; Wolmarans L; Vermaak WJ; van Lathem JJ; Kruger AJ; Pelser HH; Crause MJ
    S Afr Med J; 1991 Jul; 80(2):87-9. PubMed ID: 1677784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Multiple endocrine neoplasm type II-A].
    Díaz de Greñu Martínez C; Menéndez Torre EL; Boix Pallarés P; Aller Granda J; Díaz Cadorniga FJ; Rabal Artal A
    Med Clin (Barc); 1985 Nov; 85(18):756-8. PubMed ID: 2869204
    [No Abstract]   [Full Text] [Related]  

  • 54. Unusual features of multiple endocrine neoplasia.
    Frilling A; Becker H; Roeher HD
    Henry Ford Hosp Med J; 1992; 40(3-4):253-5. PubMed ID: 1362416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening for MEN 2 with biochemical and genetic markers.
    Robinson MF; Gagel RF; Raue F
    Recent Results Cancer Res; 1992; 125():105-23. PubMed ID: 1360168
    [No Abstract]   [Full Text] [Related]  

  • 56. [Multiple endocrine adenomatosis Type 2].
    Takai S; Miyauchi A; Masuo K
    Horumon To Rinsho; 1982 Aug; 30(8):797-801. PubMed ID: 6128092
    [No Abstract]   [Full Text] [Related]  

  • 57. [History of research on multiple endocrine neoplasia, MEN].
    Yoshimoto K
    Nihon Naika Gakkai Zasshi; 2002 Apr; 91(4):1179-83. PubMed ID: 12056016
    [No Abstract]   [Full Text] [Related]  

  • 58. [Multiple endocrine type II neoplasm].
    Toledo SP; Ferraz AR
    Rev Hosp Clin Fac Med Sao Paulo; 1990; 45(1):1-2. PubMed ID: 1983459
    [No Abstract]   [Full Text] [Related]  

  • 59. Management of medullary thyroid carcinomas.
    Hamoir M; Maisin JP; Warnier P; Ketelslegers JM; Rahier J
    Acta Otorhinolaryngol Belg; 1987; 41(5):782-92. PubMed ID: 2899945
    [No Abstract]   [Full Text] [Related]  

  • 60. Multiple endocrine neoplasia type 2b with a good prognosis.
    Kullberg BJ; Nieuwenhuijzen Kruseman AC
    Arch Intern Med; 1987 Jun; 147(6):1125-7. PubMed ID: 2884942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.